CVE Vulnerability

CVE-2021-43935

The impacted products, when configured to use SSO, are affected by an improper authentication vulnerability. This vulnerability allows the application to accept manual entry of any active directory (AD) account provisioned in the application without supplying a password, resulting in access to the application as the supplied AD account, with all associated privileges.

6.8 /10

CVSS v2.0 :

V3 Legend

Vector :

Exploitability : 8.6 / Impact : 6.4

Attack Vector

Attack Complexity

Privileges Required

User Interaction

Confidentiality Impact PARTIAL

Integrity Impact PARTIAL

Availability Impact PARTIAL

Scope

9.8 /10

CVSS v3.0 : CRITICAL

V3 Legend

Vector :

Exploitability : 3.9 / Impact : 5.9

Attack Vector NETWORK

Attack Complexity LOW

Privileges Required NONE

User Interaction NONE

Confidentiality Impact HIGH

Integrity Impact HIGH

Availability Impact HIGH

Scope UNCHANGED

References
Link Resource
https://www.cisa.gov/uscert/ics/advisories/icsma-21-343-01 Mitigation Third Party Advisory
Configurations

Configuration 1

cpe:2.3:a:baxter:welch_allyn_connex_cardio:*:*:*:*:*:*:*:*
cpe:2.3:a:baxter:welch_allyn_diagnostic_cardiology_suite:2.1.0:*:*:*:*:*:*:*
cpe:2.3:a:baxter:welch_allyn_rscribe_resting_ecg_system:*:*:*:*:*:*:*:*
cpe:2.3:a:baxter:welch_allyn_vision_express_holter_analysis_system:*:*:*:*:*:*:*:*
Information

Published : 2021-12-15 07:15

Updated : 2022-07-25 10:39

NVD link : CVE-2021-43935

Mitre link : CVE-2021-43935

Products Affected
No products.
CWE
CWE-287